Tirzepatide (10MG)

 4.3/5

Tirzepatide (10MG)

$79.99

Tirzepatide is a once-weekly injectable medication used to improve blood sugar control in adults with type 2 diabetes and support weight loss. It works by activating both GLP-1 and GIP receptors to regulate appetite, insulin release, and blood sugar levels. This product comes in a quantity of 1ea.

5 in stock (can be backordered)

Quick Payment

100% New

Fast Delivery

Shipping charges $7.00 flat

Shipping only to USA

Tirzepatide is a groundbreaking, once-weekly injectable medication approved for the treatment of type 2 diabetes and chronic weight management. It is the first-in-class dual incretin agonist, meaning it activates two key hormone receptors: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism helps improve blood sugar control while significantly reducing body weight. Always use under the guidance of a healthcare provider.

Dual-Incretin Mechanism

Activates both GLP-1 and GIP receptors for superior metabolic control
Offers broader and more effective treatment than single-hormone drugs like semaglutide

Potent Weight Loss Support

Clinical trials show 15–22% average body weight reduction, even in non-diabetic patients
Effective for long-term obesity management when paired with lifestyle changes

Cardiometabolic Benefits

Improves insulin sensitivity, lowers blood pressure, and reduces lipid levels
May reduce risk factors for cardiovascular disease (outcomes under ongoing study)